Health Recommendation System using Deep Learning-based Collaborative Filtering | JoVE Visualize

Area of Science:

Artificial Intelligence in Healthcare
Data Mining and Machine Learning Applications
Health Informatics and Decision Support Systems

Background:

Modern healthcare necessitates intelligent systems for analyzing vast medical data to aid prediction and diagnosis.
Health Recommendation Systems (HRS) are crucial for efficient healthcare networks, ensuring data integrity, security, and privacy.
Social media data offers insights into patient health, driving the need for systems that can process diverse information sources.

Purpose of the Study:

To present an intelligent Health Recommendation System (HRS) leveraging deep learning for enhanced medical decision-making.
To explore the application of data mining techniques for creating effective and efficient health recommendation engines.
To demonstrate the potential for personalized healthcare and pharmaceutical insights through advanced data analysis.

Main Methods:

Development of a novel HRS utilizing a deep learning architecture: Restricted Boltzmann Machine (RBM)-Coevolutionary Neural Network (CNN).
Implementation of the proposed system using TensorFlow and Python for data processing and analysis.
Evaluation of system performance through distinct error metrics, accuracy, precision, recall, and F-measure against alternative methods.

Main Results:

The proposed intelligent HRS demonstrates effective analysis of patient health information, social activities, and behavior.
Performance evaluation indicates competitive accuracy, precision, recall, and F-measure compared to existing healthcare recommendation methods.
The system offers insights for diagnosis recommendations, medical insurance, care strategies, and homeopathic remedies.

Conclusions:

The developed deep learning-based HRS provides an efficient and effective engine for personalized healthcare recommendations.
Integrating multidisciplinary data sources via this system can reduce healthcare burdens and costs.
The approach highlights the pharmaceutical industry's transition towards more personalized medicine strategies.